Marshall Wace, LLP Ptc Therapeutics, Inc. Transaction History

Marshall Wace, LLP

$63.3 Billion
Q1 2024

A detailed history of Marshall Wace, LLP transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 22,219 shares of PTCT stock, worth $725,005. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,219

Holding current value

$725,005

% of portfolio

0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$24.15 - $31.95 $536,588 - $709,897	22,219 New	22,219 $646,000
Q2 2023 Aug 14, 2023	BUY	$40.4 - $59.1 $249,752 - $365,356	6,182 New	6,182 $251,000
Q1 2022 May 16, 2022	SELL	$33.33 - $44.6 $201,379 - $269,473	-6,042 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$37.95 - $49.37 $1.37 Million - $1.79 Million	-36,215 Reduced 85.7%	6,042 $255,000
Q1 2021 May 17, 2021	BUY	$46.8 - $68.92 $1.98 Million - $2.91 Million	42,257 New	42,257 $2 Million

Q4 2020 Feb 16, 2021	SELL	$47.96 - $67.64 $1.43 Million - $2.02 Million	-29,800 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$45.41 - $57.07 $216,878 - $272,566	-4,776 Reduced 13.81%	29,800 $1.39 Million
Q2 2020 Aug 13, 2020	BUY	$42.56 - $54.98 $1.47 Million - $1.9 Million	34,576 New	34,576 $1.75 Million
Q1 2020 May 15, 2020	SELL	$32.37 - $59.36 $861,527 - $1.58 Million	-26,615 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$32.22 - $50.07 $6.7 Million - $10.4 Million	-207,941 Reduced 88.65%	26,615 $1.28 Million
Q3 2019 Nov 14, 2019	BUY	$33.82 - $48.17 $7.93 Million - $11.3 Million	234,556 New	234,556 $7.93 Million
Q1 2019 May 14, 2019	SELL	$28.09 - $39.49 $720,002 - $1.01 Million	-25,632 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$29.83 - $46.51 $764,602 - $1.19 Million	25,632 New	25,632 $880,000
Q3 2018 Nov 14, 2018	SELL	$33.9 - $47.77 $687,424 - $968,680	-20,278 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$25.7 - $47.88 $521,144 - $970,910	20,278 New	20,278 $684,000

Others Institutions Holding PTCT

# of Institutions

200

Shares Held

83.9M

Call Options Held

192K

Put Options Held

129K

Vanguard Group Inc Valley Forge, PA

9.37M
Shares

$306 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

8.9M
Shares

$290 Million
0.05% of portfolio
Black Rock Inc. New York, NY

7.57M
Shares

$247 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

7.42M
Shares

$242 Million
3.47% of portfolio
Armistice Capital, LLC New York, NY

6.76M
Shares

$221 Million
2.68% of portfolio

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.33B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account